177A — Kohjin Bio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Kohjin Bio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho
Standards:	JAS	JAS	JAS
Status:	Final	Final	Final
Revenue
Total Revenue	3,947	4,743	4,770
Cost of Revenue
Gross Profit	2,039	2,454	1,881
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,974	3,476	4,173
Operating Profit	973	1,267	597
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	922	1,244	636
Provision for Income Taxes
Net Income After Taxes	588	830	385
Net Income Before Extraordinary Items
Net Income	588	830	385
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	588	830	385
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	117	165	76.8
Dividends per Share